SCHEMBL7076802

SCHEMBL7076802

Fc1cccc(CC2CC3CCC(C2)N3Cc2nc3ccccc3[nH]2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 5/20 0.56
GRIN1 Q05586 4/20 0.56
CXCR6 O00574 1/20 0.45
OPRM1 P35372 1/20 0.43
OPRD1 P41143 1/20 0.43
OPRK1 P41145 1/20 0.43
KCNH2 Q12809 1/20 0.43
KMT2A Q03164 2/20 0.43
NPC1 O15118 1/20 0.43
DRD4 P21917 2/20 0.43
HTT P42858 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
CASP1 P29466 1/20 0.42
HSD17B10 Q99714 1/20 0.42
IDO1 P14902 1/20 0.41
CHRM2 P08172 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7075826 0.88 GRIN1 (0.56) GRIN2BGRIN1CXCR6KMT2ANPC1
SCHEMBL7072578 0.88 GRIN2B (0.67) GRIN2BGRIN1CXCR6NPC1DRD4
SCHEMBL7073348 0.88 GRIN1 (0.53) GRIN2BGRIN1CXCR6OPRM1OPRD1
SCHEMBL7072074 0.88 GRIN1 (0.53) GRIN2BGRIN1CXCR6OPRM1OPRD1
SCHEMBL7079118 0.83 GRIN1 (0.50) GRIN2BGRIN1CXCR6OPRM1OPRD1
SCHEMBL7074921 0.82 GRIN2B (0.56) GRIN2BGRIN1CXCR6KMT2ANPC1
SCHEMBL7077264 0.82 GRIN1 (0.54) GRIN2BGRIN1CXCR6NPC1DRD4
SCHEMBL7074975 0.82 GRIN1 (0.56) GRIN2BGRIN1CXCR6KMT2ANPC1
SCHEMBL7072398 0.79 GRIN1 (0.53) GRIN2BGRIN1CXCR6KCNH2KMT2A
SCHEMBL7071858 0.78 MEN1 (0.49) GRIN2BGRIN1CXCR6KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1244450-A4 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS MERCK & CO INC (US) 2003-03-19 EP claimed
EP-1244450-A1 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS Merck & Co., Inc. (US) 2002-10-02 EP claimed
US-6432976-B1 ANALGESICS; SIDE EFFECT REDUCTION MERCK & CO., INC. 2002-08-13 US claimed
WO-2001032179-A1 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2001-05-10 WO claimed
EP-1244450-A4 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS MERCK & CO INC (US) 2003-03-19 EP disclosed
EP-1244450-A1 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS Merck & Co., Inc. (US) 2002-10-02 EP disclosed
US-6432976-B1 ANALGESICS; SIDE EFFECT REDUCTION MERCK & CO., INC. 2002-08-13 US disclosed
WO-2001032179-A1 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2001-05-10 WO disclosed